Straits Times Index
3,316.56 -6.06 (-0.18%) Nikkei
38,646.11 -457.11 (-1.17%) Hang Seng
18,608.94 -259.77 (-1.38%) FTSE 100
8,317.59 -21.64 (-0.26%) Bitcoin USD
68,598.09 +704.88 (+1.04%) CMC Crypto 200
1,433.65 -34.45 (-2.37%)
VEEV Dec 2024 200.000 put
| Previous close | 15.64 |
| Open | 15.50 |
| Bid | 12.10 |
| Ask | 15.10 |
| Strike | 200.00 |
| Expiry date | 2024-12-20 |
| Day's range | 15.50 - 15.64 |
| Contract range | N/A |
| Volume | |
| Open interest | 12 |
ZacksVeeva (VEEV) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Veeva (VEEV) for the quarter ended April 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
ZacksWorkday (WDAY) Q1 Earnings and Revenues Surpass Estimates
Workday (WDAY) delivered earnings and revenue surprises of 10.83% and 0.84%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireNew Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops
Veeva Systems (NYSE: VEEV) today unveiled the latest findings from its Veeva Pulse Field Trends Report. The analysis finds that healthcare professional (HCP) access has returned to its pre-pandemic state. Today, 45% of HCPs are accessible to biopharmas compared to 60% eighteen months ago, with half restricting engagement to three or fewer companies.
